Pedro Lichtinger, Chief Executive Officer at Asterias Biotherapeutics, Inc. (AST), bought 128,205 shares at $3.90 ($500K) on 2015-02-09, disclosed to the SEC on 2015-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OPTR | SELL | 2013-04-10 | $2.2M | — | Filing → |
| OPTR | BUY | 2012-11-19 | $100K | — | Filing → |
| BTX | BUY | 2012-04-12 | $25K | — | Filing → |